Osmotic system with distribution zone for dispensing beneficial agent

• US 4,200,098 A
• Filed: 10/23/1978
• Issued: 04/29/1980
• Est. Priority Date: 10/23/1978
• Status: Expired due to Term

• Current Assignee: ALZA Corporation (Johnson & Johnson)
• Original Assignee: ALZA Corporation (Johnson & Johnson)
• Inventors: Ayer, Atul D., Theeuwes, Felix
• Primary Examiner(s): Michell, Robert W.
• Assistant Examiner(s): Rosenbaum, C. F.
• Application Number:
  US05/953,906
• Time in Patent Office: 554 Days
• Field of Search: 128/127, 128/130, 128/213 R, 128/222, 128/260-261, 128/270-271, 424/19, 424/22, 424/16, 428/420, 428/532-533, 521/61, 521/63, 106/169
• US Class Current: 424/424
• CPC Class Codes: A61K 9/0004 Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
• CPC Class Codes: Y10T 428/31536 Including interfacial reaction product of adjacent layers

Abstract

An osmotic system is disclosed for dispensing a beneficial agent. The system comprises (1) a first wall of a semipermeable material that surrounds a compartment containing a drug formulation, and has a passageway through the wall for releasing agent from the compartment, (2) a second wall positioned distant from the first wall, said second wall a microporous or hydrogel material that extends around the first wall, and (3) a distribution zone interposed between the first and second wall and initially housing a compound soluble in an external fluid that enters the system.

In operation, agent is dispensed from the system by fluid passing through the second wall into the zone from which fluid is further being imbibed through the first wall into the compartment forming a solution that is released through the passageway into the zone, and then through the second wall to the exterior of the system.

Claims

1. A laminate useful for manufacturing a device for dispensing a beneficial agent to a fluid environment of use, said laminate comprising a first lamina formed of a member selected from the group consisting of cellulose acylate, cellulose diacylate and cellulose triacylate, a third lamina spaced distant from the first lamina, said third lamina formed of a composition comprising a polymer and a pore-former selected from the group consisting of carbohydrates and salts dispersed in the polymer, which polymer is a member selected from the group consisting of cellulose acylate, cellulose discylate and cellulose triacylate, and a second lamina positioned between the first and third lamina which second lamina is formed of a member selected from the group consisting of essentially salt and carbohydrate soluble in the fluid present in the environment of use.

2. A three-layered laminate useful for manufacturing a device for dispensing a drug to a biological fluid environment of use, said laminate comprising a first lamina formed of a semipermeable polymer permeable to the passage of drug, a second lamina in laminar arrangement with the first lamina, said second lamina formed of a member selected from the group consisting of a carbohydrate, an organic and inorganic salt, and a third lamina in laminar arrangement with the second lamina, said third lamina formed of a polymer having a micropore forming agent distributed therein, which agent is soluble in the biological fluid and when the laminate is in the environment of use, the agent is leached from the polymer to form a microporous polymer.

3. The laminate useful for manufacturing the device for dispensing the drug to the biological environment according to claim 2, wherein the first lamina is a semipermeable polymer selected from the group consisting of cellulose acetate, cellulose diacetate and cellulose triacetate.

4. The laminate useful for manufacturing the device for dispensing the drug to the biological environment according to claim 2, wherein the third lamina comprises a polymer selected from the group consisting of a cellulose ester and cellulose ether, which polymer has pore-formers dispersed therein selected from the group consisting of glucose, sucrose, fructose, raffinose, lactose, mannitol, sorbitol, mannose, glactose, aldohexose, altrose and lalose.

5. A laminate useful for manufacturing a device for dispensing a drug to a biological environment of use, said laminate comprising a first lamina formed of a member selected from the group consisting essentially of a cellulose acylate, cellulose diacylate and cellulose triacylate, a second lamina laminated to the first lamina, said second lamina consisting essentially of a member selected from the group consisting of an aqueous and biological fluid soluble carbohydrate and salt, and a third lamina laminated to the second lamina, said third lamina formed of a hydrophilic polymer that maintains its physical and chemical integrity in the environment of use, and which hydrophilic polymer has a pore-forming agent dispersed therein.

6. An osmotic system for dispensing a beneficial agent to an environment of use, said system comprising:

(a) a first wall formed a semipermeable material permeable to the passage of fluid present in the environment of use and substantially impermeable to the passage of beneficial agent;

a second wall formed of a polymer that maintains its physical and chemical integrity during the dispensing period and contains a pore forming agent dispersed therein, said second wall spaced distant and around the first wall; and

, a layer formed of a compound soluble in fluid that enters the compartment positioned between the first and second walls;

said walls surrounding with the first wall facing;

(b) a compartment;

(c) a beneficial agent housed in the compartment; and

,

(d) a passageway in the first wall communicating the compartment with the layer.

7. The osmotic system for dispensing the beneficial agent according to claim 6, wherein, when the system is in operation in an environment of use, fluid from the environment leaches the pore forming agent from the second wall thereby forming a microporous wall, with fluid passing through the pore, dissolving the layer and forming a fluid zone between the second and first walls, with said fluid imbibed through the first wall into the compartment in a tendency toward osmotic equilibrium at a rate determined by the permeability of the first wall and the osmotic pressure gradient across the first wall, thereby forming a solution containing beneficial agent that is released through the passageway into the zone and through the pore to the environment of use at a controlled rate over a prolonged period of time.

8. The osmotic system for dispensing the beneficial agent according to claim 6, wherein the compound forming the layer between the first and second walls is a member selected from the group consisting of inorganic and organic compounds that form a solution with water that enters the system from the environment, which solution can pass through the micropores of the second wall to the exterior of the system.

9. The osmotic system for dispensing the beneficial agent according to claim 6, wherein the pore forming agent in the second wall is a member selected from the group consisting of inorganic salts, organic salts and carbohydrates that are leached from said wall when the system is in an aqueous environment.

10. The osmotic system for dispensing the beneficial agent according to claim 6, wherein the second wall is formed of a member selected from the group of polymers consisting of cellulose acylate, cellulose diacylate and cellulose triacylate, which polymer has a pore forming agent selected from the group consisting of water soluble salts and carbohydrates dispersed therein.

11. The osmotic system for dispensing the beneficial agent according to claim 6, wherein the beneficial agent is present in the compartment with an osmotically effective solute that exhibits an osmotic pressure gradient across the first wall against a fluid present in the fluid zone between the first and second walls.

12. The osmotic system for dispensing the beneficial agent according to claim 6, wherein the first wall is formed of a polymer selected from the group consisting of cellulose esters and cellulose ethers, which polymer has a flux regulator dispersed therein that enhances the permeability of the first wall to the passage of fluid.

13. An osmotic system for dispensing a beneficial agent to a fluid environment of use, said system comprising:

(a) (1) a first wall formed of a semipermeable polymer permeable to the passage of fluid and substantially impermeable to the passage of beneficial agent, (2) a second wall formed of a hydrophilic hydrogel that maintains its physical and chemical integrity in the environment of use and during the dispensing of beneficial agent, said second wall in spaced relation from and extended around the first wall, and (3) a layer formed of a compound soluble in fluid that enters the system positioned between the first and second walls;

said wall surrounding with the first wall facing;

(b) a compartment;

(c) a beneficial agent housed in the compartment; and

,

(d) a passageway in the first wall connecting the compartment with the layer.

14. An osmotic therapeutic system sized, shaped and adapted for dispensing a drug to a biological environment of use, said therapeutic system comprising:

(a) a pair of walls, said pair comprising (1) an inside wall formed of a semipermeable material permeable to the passage of a biological fluid and substantially impermeable to the passage of drug, (2) an outside wall spaced distant and around the inside wall, said outside wall formed of a polymer that keeps its physical and chemical integrity during the dispensing period and has a micropore forming agent dispersed therein;

(3) a distribution zone between the inside and outside walls, said zone housing a compound that is soluble in fluid that enters the system; and

, wherein the walls surround and form with the inside wall facing;

(b) a compartment;

(c) a drug selected from the group consisting of locally acting and systemically acting drugs housed in the compartment; and

,

(d) a passageway in the inside wall communicating with the compartment and the zone between the walls.

15. The osmotic therapeutic system according to claim 14, wherein the system is sized, shaped and adapted for the controlled dispensing of drug in a gastrointestinal environment of use.

16. The osmotic therapeutic system according to claim 14, wherein the system is sized, shaped and adapted for the controlled dispensing of drug in a ano-rectal environment of use.

17. The osmotic therapeutic system according to claim 14, wherein the environment of use is a vagina and the system is sized, shaped and adapted for the controlled dispensing of drug to said environment.

18. The osmotic therapeutic system according to claim 14, wherein the environment of use is the ano-rectal canal and the inside wall of the system is formed of a member selected from the group consisting of cellulose acylate, cellulose diacylate and cellulose triacylate.

19. The osmotic therapeutic system according to claim 14, wherein the environment of use is the vagina, and the inside wall comprises a member selected from the group consisting of cellulose acylate, cellulose diacylate and cellulose triacylate.

20. The osmotic therapeutic system for the controlled dispensing of locally and systemically acting drugs according to claim 14, wherein the compartment housing the drug contains an osmotically effective solute that is soluble in fluid that enters the compartment when the system is in the environment of use.

21. The osmotic therapeutic system according to claim 14, wherein, when the environment of use is an animal and the system is dispensing drug thereto, (a) fluid from said environment leaches the micropore-forming agent from the outside wall forming a microporous wall, with (b) fluid passing through the micropores into the zone, dissolving the compound and forming a fluid zone between the walls, with (c) fluid being imbibed from the zone through the inside wall into the compartment in a tendency towards osmotic equilibrium at a rate determined by the permeability of the inside wall and the osmotic pressure gradient across the inside wall, thereby (d) forming a drug formulation that is released through the passageway into the zone and (e) from said zone through the micropores to the environment of use at a controlled rate over a prolonged period of time.

22. The osmotic therapeutic system for the controlled dispensing of drug according to claim 14, wherein the outside wall is formed of a member selected from the group consisting of cellulose esters and cellulose ethers, said member having a micropore forming agent selected from the group consisting of an alkali metal salt, alkaline earth metal salt, aliphatic diols and polyols, aromatic diols and polyols, and a carbohydrate dispersed therein.